Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach

Keyphrases

• Myelodysplastic Syndrome 100%
• Multimodal Approach 100%
• Allogeneic Transplant 100%
• Pretransplant 100%
• Dysplasia 66%
• Allogeneic Hematopoietic Cell Transplant 66%
• Abnormal Clones 66%
• Clinical Features 33%
• Acute Myeloid Leukemia 33%
• Medical Records 33%
• Marrow 33%
• Bone Marrow 33%
• Engraftment 33%
• Peripheral Blood 33%
• Clonal Evolution 33%
• Myeloid Neoplasms 33%
• Relapse Rate 33%
• Morphological Characteristics 33%
• Median Time 33%
• Cytogenetic Analysis 33%
• Chimerism 33%
• Granulocytic 33%
• Curative Treatment 33%
• Time to Relapse 33%
• Clinicopathologic Study 33%
• Blast Count 33%
• Erythroid Hyperplasia 33%
• Megakaryocyte Dysplasia 33%
• Dysplastic Megakaryocytes 33%
• Marrow Cellularity 33%

Medicine and Dentistry

• Myelodysplastic Syndrome 100%
• Dysplasia 100%
• Hematopoietic Cell 50%
• Megakaryocyte 50%
• Diseases 50%
• Morphology 25%
• Neoplasm 25%
• Engraftment 25%
• Clinical Feature 25%
• Acute Myeloid Leukemia 25%
• Medical Record 25%
• Recurrence Risk 25%
• Chromosome Analysis 25%
• Bone Marrow Biopsy 25%